BioCube, Inc.
BICB
$0.0002
-$0.0022-91.67%
| 07/31/2013 | 04/30/2013 | 01/31/2013 | 10/31/2012 | 07/31/2012 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.39% | 51.29% | 34.80% | 12.65% | 2.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.39% | 51.29% | 34.80% | 12.65% | 2.11% |
| Operating Income | -2.39% | -51.29% | -34.80% | -12.65% | -2.11% |
| Income Before Tax | -219.39% | -122.90% | -734.61% | 27.01% | 62.63% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -219.39% | -122.90% | -734.61% | 27.01% | 62.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -219.39% | -122.90% | -734.61% | 27.01% | 62.63% |
| EBIT | -2.39% | -51.29% | -34.80% | -12.65% | -2.11% |
| EBITDA | 57.82% | 9.52% | -28.70% | 49.47% | 48.95% |
| EPS Basic | -170.10% | -88.65% | -636.36% | 20.96% | 56.89% |
| Normalized Basic EPS | -3,380.00% | -2,162.50% | -378.33% | 14.52% | 107.69% |
| EPS Diluted | -170.10% | -88.65% | -636.36% | 20.96% | 56.89% |
| Normalized Diluted EPS | -3,380.00% | -2,162.50% | -378.33% | 14.52% | 107.69% |
| Average Basic Shares Outstanding | 34.62% | 24.69% | 8.60% | 1.93% | -0.87% |
| Average Diluted Shares Outstanding | 34.62% | 24.69% | 8.60% | 1.93% | -0.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
